MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202441032690 A) filed by RK Pharma Inc, Pearl River, U.S.A., on April 25, 2024, for 'pharmaceutical formulations of cagrilintide and semaglutide.'
Inventor(s) include Ravishanker Kovi; Vure Prasad; and Shavkar Sharada Devi.
The application for the patent was published on Oct. 31, under issue no. 44/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to pharmaceutical formulations of Cagrilintide and Semaglutide. The present invention further relates to parenteral pharmaceutical formulations of Semaglutide and Cagrilintide to be co-administered using a kit. The present invention further relates ...